Next Article in Journal
AI-Assisted Detection and Localization of Spinal Metastatic Lesions
Next Article in Special Issue
Pancreatic Neuroendocrine Tumors—Diagnostic Pitfalls of Non-Diabetic Severe Hypoglycemia: Literature Review and Case Report
Previous Article in Journal
Using Key Predictors in an SVM Model for Differentiating Spinal Fractures and Herniated Intervertebral Discs in Preoperative Anesthesia Evaluation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diagnostics
Volume 14
Issue 21
10.3390/diagnostics14212457
diagnostics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT

by
Huijia Zhao
1,2,
Qiang Xu
1,2,
Ruichen Gao
1,2,
Bohui Yin
1,2,
Gan Sun
3,
Ke Xue
4,
Yuxin Yang
4,
Enhui Li
4,
Liang Zhu
2,5,*,
Feng Feng
2,5 and
Wenming Wu
1,2,*
1
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China
2
State Key Laboratory of Complex Severe and Rare Diseases, Beijing 100730, China
3
Theranostics and Translational Research Center, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
4
United Imaging Research Institute of Intelligent Imaging, Beijing 100089, China
5
Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China
*
Authors to whom correspondence should be addressed.
Diagnostics 2024, 14(21), 2457; https://doi.org/10.3390/diagnostics14212457
Submission received: 1 October 2024 / Revised: 28 October 2024 / Accepted: 30 October 2024 / Published: 2 November 2024
(This article belongs to the Special Issue Diagnosis of Pancreatic Diseases)
Browse Figures
Versions Notes

Abstract

Objectives: To assess the feasibility of 5.0 T magnetic resonance imaging (MRI) in characterizing pancreatic cystic lesions (PCLs), compared with 3.0 T MRI and multidetector computed tomography (MDCT). Methods: Thirty-five patients with PCLs underwent 5.0 T MR alongside 3.0 T MR or MDCT. Two observers measured subjective and objective image quality scores. The consistency of two observers between 5.0 T and 3.0 T was calculated by intraclass correlation coefficients. The characteristics of PCLs and their specific diagnosis, as well as benignity/malignancy, were evaluated across MDCT, 3.0 T, and 5.0 T MRI. Results: The 5.0 T MR demonstrated significantly higher subjective image quality and SNR on T1WI compared to that in 3.0 T MR (p < 0.05). The 5.0 T MRI identified more cyst lesions than the 3.0 T MRI (40 and 32) and MDCT (82 and 56). The sensitivity, specificity, and accuracy for differentiating benign from malignant lesions with 5.0 T MRI (75%, 100%, and 91.4%, respectively) surpassed those of 3.0 T MRI and MDCT. The accuracy of the specific diagnosis of PCLs at 5.0 T MRI (80%) was superior to 3.0 T MRI and MDCT. Conclusions: 5.0 T MRI exhibits certain superiority in delineating details of PCLs and in clinical diagnostic accuracy, outperforming MDCT and 3.0 T MRI while maintaining sufficient image quality.
Keywords: 5.0 T MRI; pancreatic cystic lesions; image quality; diagnostic accuracy 5.0 T MRI; pancreatic cystic lesions; image quality; diagnostic accuracy

Share and Cite

MDPI and ACS Style

Zhao, H.; Xu, Q.; Gao, R.; Yin, B.; Sun, G.; Xue, K.; Yang, Y.; Li, E.; Zhu, L.; Feng, F.; et al. Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT. Diagnostics 2024, 14, 2457. https://doi.org/10.3390/diagnostics14212457

AMA Style

Zhao H, Xu Q, Gao R, Yin B, Sun G, Xue K, Yang Y, Li E, Zhu L, Feng F, et al. Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT. Diagnostics. 2024; 14(21):2457. https://doi.org/10.3390/diagnostics14212457

Chicago/Turabian Style

Zhao, Huijia, Qiang Xu, Ruichen Gao, Bohui Yin, Gan Sun, Ke Xue, Yuxin Yang, Enhui Li, Liang Zhu, Feng Feng, and et al. 2024. "Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT" Diagnostics 14, no. 21: 2457. https://doi.org/10.3390/diagnostics14212457

APA Style

Zhao, H., Xu, Q., Gao, R., Yin, B., Sun, G., Xue, K., Yang, Y., Li, E., Zhu, L., Feng, F., & Wu, W. (2024). Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT. Diagnostics, 14(21), 2457. https://doi.org/10.3390/diagnostics14212457

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop